From 2002 to 2020, there were over 1,000 mergers of US hospitals. During this period, the Federal Trade Commission (FTC) took enforcement actions against 13 transactions. However, using the FTC’s standard screening tools, we find that 20% of these mergers could have been predicted to meaningfully lessen competition. We then show that, from 2010 to 2015, predictably anticompetitive mergers resulted in price increases over 5%. We estimate that approximately half of predictably anticompetitive mergers had to be reported to the FTC per the Hart-Scott-Rodino Act. We conclude that there appears to be underenforcement of antitrust laws in the hospital sector.

More on this topic

BFI Working Paper·Sep 18, 2025

The Five Shanghai Themes

Harald Uhlig
Topics: Economic Mobility & Poverty, Energy & Environment, Financial Markets, Health care
BFI Working Paper·Aug 13, 2025

Post-Roe Planning: The Effect of Dobbs v. Jackson on Contraceptive and Sterilization Choices

Yana Gallen and Daisy Lu
Topics: Health care
BFI Working Paper·Aug 7, 2025

Pharmacy Benefit Managers and Vertical Relationships in Drug Supply

Zarek Brot-Goldberg, Catherine Che, and Benjamin Handel
Topics: Health care